How much funding has MITOTHERAPEUTIX, LLC raised?

MITOTHERAPEUTIX, LLC has raised $7.2M in total funding, most recently a pre seed round.

Who are MITOTHERAPEUTIX, LLC's investors?

MITOTHERAPEUTIX, LLC's investors include Oshen Holdings SA, Fink Family Office.

When was MITOTHERAPEUTIX, LLC founded?

MITOTHERAPEUTIX, LLC was founded in 2017.

Where is MITOTHERAPEUTIX, LLC headquartered?

MITOTHERAPEUTIX, LLC is headquartered in FARMINGTON, Connecticut, United States.

What industry is MITOTHERAPEUTIX, LLC in?

MITOTHERAPEUTIX, LLC operates in Biotech, Healthcare.

How many employees does MITOTHERAPEUTIX, LLC have?

MITOTHERAPEUTIX, LLC has 1-10 employees.

MITOTHERAPEUTIX, LLC

Using the power of RNA silencing to impact disease.

FARMINGTON, United States · Founded 2017 · $7.2M raised

Biotech

Healthcare

Headquarters: FARMINGTON, Connecticut
Employees: 1–10
Founded: 2017
Business Model: B2B

Website: mitotherapeutix.com
Total Funding: $7.2M
Last Round: $7.2M Pre-SeedNov 2025
Rounds: 1

About

Mitotherapeutix is a pre-clinical stage pharmaceutical company developing siRNA-based drugs that target a novel mitochondrial protein (MCJ/DNAJC15) responsible for regulating cellular metabolism. By silencing this metabolic regulator, the company aims to safely increase mitochondrial energy production, with potential therapeutic applications across multiple diseases.

Summary

MITOTHERAPEUTIX, LLC is a Biotech company based in FARMINGTON, United States, founded in 2017. It has raised $7.2M in total across 1 round, most recently a $7.2M Pre-Seed round in Nov 2025. Investors include Oshen Holdings SA and Fink Family Office.